Stay updated on Dupilumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page
- Check3 days agoChange DetectedThe revision label was updated from v3.5.4 to v3.5.5, indicating a minor metadata update to the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page content.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, reflecting a maintenance update to the page's software version. No study content, data, or results were modified.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 removed. This is a site version update that does not modify study content or user actions.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision tag on the page updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.